S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Case Western Reserve University to Study Pluristem's PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases|
|New Published Data Show Pluristem's PLX Cells Protect Neurons|
|Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes|
|Pluristem Issues Letter to Shareholders|
|Pluristem Advances Its Second Major Cell Therapy Product Line From Development to Large-Scale Manufacturing|
|Avago Technologies Limited Announces Fourth Quarter and Fiscal Year 2014 Financial Results|
|Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple Indications|
|Pluristem Wins Cell Therapy Patent Case in Europe; European Patent Office Confirms Validity of Amended Claims|
|Entropic Reports Third Quarter 2014 Results|
|Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014|
Click above to view more mutual fund data and stats for plx - Protalix BioTherapeutics Inc.